Search

Your search keyword '"Miura, Satoru"' showing total 690 results

Search Constraints

Start Over You searched for: Author "Miura, Satoru" Remove constraint Author: "Miura, Satoru"
690 results on '"Miura, Satoru"'

Search Results

202. Sub-target effect in film analysis using TEA CO2 laser-induced plasma

204. Afatinib for the Treatment of NSCLC Harboring Uncommon EGFRMutations: A Database of 693 Cases

205. Influence of Polymer Dispersant on the Granulation of Raw Materials for Sintering Process

206. Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non‐small‐cell lung cancer.

207. Real-World Pharmacokinetics, Effectiveness, and Safety of Atezolizumab in Patients with Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer: An Exploratory Study of J-TAIL

208. Characteristics of initial deposition and behavior of radiocesium in forest ecosystems of different locations and species affected by the Fukushima Daiichi Nuclear Power Plant accident

210. Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors

212. ゲフィチニブによる腸管気腫症発症後に安全にエルロチニブを投与しえた肺腺癌の1例

217. Docetaxel Plus Ramucirumab With Primary Prophylactic Pegylated Granulocyte-Colony Stimulating Factor Support for Elderly Patients With Advanced NSCLC: A Multicenter Prospective Single Arm Phase 2 Trial: DRAGON Study (WJOG9416L)

218. Abstract 3153: Critical roles of chemo-resistant effector and regulatory T cells in cancer immunotherapy during hemostatic proliferation

219. Critical Roles of Chemoresistant Effector and Regulatory T Cells in Antitumor Immunity after Lymphodepleting Chemotherapy

220. The efficacy of amrubicin on central nervous system metastases originating from small-cell lung cancer: a case series of eight patients

221. Advanced Thymic Cancer Treated with Carboplatin and Paclitaxel in a Patient Undergoing Hemodialysis

223. A phase II study of erlotinib monotherapy in pre-treated non-small cell lung cancer without EGFR gene mutation who have never/light smoking history: Re-evaluation of EGFR gene status (NEJ006/TCOG0903)

224. Analysis of heavy metal pollution in soil using transversely excited atmospheric CO2 laser-induced plasma by trapping the soil in microstructured holes on metal subtargets

226. Carbon analysis for inspecting carbonation of concrete using a TEA CO2 laser-induced plasma

227. O6-3 The significance of ultra-low EGFR T790M mutations on EGFR-TKI efficacy in patients with NSCLC -the WJOG13119L study.

228. Measurement of concrete strength using the emission intensity ratio between Ca(II) 396.8 nm and Ca(I) 422.6 nm in a Nd:YAG laser-induced plasma

229. A phase II study of carboplatin plus weekly paclitaxel with bevacizumab for elderly patients with non-squamous non-small-cell lung cancer (NEJ016).

231. Outcomes of Chemoimmunotherapy Among Patients With Extensive-Stage Small Cell Lung Cancer According to Potential Clinical Trial Eligibility.

235. Abstract 2818: Dendritic cell vaccination and regulatory T-cell depletion augment antitumor immunity after cytotoxic therapy

237. Abstract 200: DDX3X induces signal switching to stem cell-specific Wnt/β-catenin signaling, resulting in EGFR-TKI resistance in lung cancer cells harboring EGFR activating mutation

239. Phase I study of dose-dense chemotherapy (DDC) alternating cisplatin (CDDP), topotecan (TPT), and paclitaxel (PTX) with CDDP, amrubicin (AMR), and PTX under granulocyte colony-stimulating factor support for extensive-stage small-cell lung cancer (ES-SCLC).

247. ペメトレキセドを含むプラチナ併用化学療法により長期生存が得られた原発性心膜悪性中皮腫の1例

249. 副腎転移巣から出血をきたした肺癌と胃癌の重複癌の1例

Catalog

Books, media, physical & digital resources